Your browser doesn't support javascript.
loading
ATR inhibition preferentially targets homologous recombination-deficient tumor cells.
Krajewska, M; Fehrmann, R S N; Schoonen, P M; Labib, S; de Vries, E G E; Franke, L; van Vugt, M A T M.
Afiliação
  • Krajewska M; Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Fehrmann RS; Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Schoonen PM; Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Labib S; Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • de Vries EG; Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.
  • Franke L; Department of Medical Genetics, University Medical Center Groningen, University of Groningen, The Netherlands.
  • van Vugt MA; Department of Medical Onclology, University Medical Center Groningen, University of Groningen, The Netherlands.
Oncogene ; 34(26): 3474-81, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25174396
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinas / Sulfonas / Recombinação Homóloga / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncogene Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinas / Sulfonas / Recombinação Homóloga / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Oncogene Ano de publicação: 2015 Tipo de documento: Article